A significant step in unraveling the connection between PCSK9 and cardiovascular aging involved a highly significant study by the Pacher laboratory that measured plasma PCSK9 levels in individuals across various age groups [ 1 ].
← all excerpts
PCSK9: an emerging player in cardiometabolic aging and its potential as a therapeutic target and biomarker.
1
—
—